[Early detection and modification of preclinical arteriosclerosis].
Rudofsky
G
G
Klinik und Poliklinik für Angiologie, Klinikums, Universität Essen.
D000924:Anticholesteremic Agents / Q000008:administration & dosage; D001161:Arteriosclerosis / Q000000981:diagnostic imaging* / Q000517:prevention & control; D001241:Aspirin / Q000008:administration & dosage; D004176:Dipyridamole / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000000981:diagnostic imaging; D005500:Follow-Up Studies; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000000981:diagnostic imaging; D009257:Nafronyl / Q000008:administration & dosage; D010713:Phosphatidylcholines / Q000008:administration & dosage; D011446:Prospective Studies; D012307:Risk Factors; D014463:Ultrasonography
D000924:Anticholesteremic Agents; D010713:Phosphatidylcholines; C011246:essential 303 forte; D009257:Nafronyl; D004176:Dipyridamole; D001241:Aspirin
Früherkennung und Beeinflussung der präklinischen Arteriosklerose.